Thu Jan 09 23:54:14 UTC 2025: ## Standard Glass Lining IPO Oversubscribed, Poised for Strong Listing

**Mumbai, January 12** – Standard Glass Lining Ltd.’s initial public offering (IPO), which closed on January 8th, was massively oversubscribed, receiving a total subscription of 185.48 times. The retail portion saw 65.71 times oversubscription, while non-institutional investors (NII) and qualified institutional buyers (QIB) subscribed 275.21 and 327.76 times, respectively. The IPO, priced between ₹133 and ₹140 per share, raised ₹410.05 crore.

Investors can now check their allotment status on the BSE and NSE websites, or through registrar Kfin Technologies’ portal (links provided below). Shares are set to list on both exchanges on Monday, January 13th.

Market observers predict a strong listing, citing a grey market premium (GMP) of ₹78, representing a 55.71% increase over the issue price. This puts the unofficial trading price around ₹218 per share. The company intends to use the ₹210 crore raised from fresh equity issuance for debt repayment, investment in a subsidiary, strategic acquisitions, and purchasing machinery.

Standard Glass Lining provides turnkey solutions for pharmaceutical and chemical manufacturers, boasting a client roster that includes prominent names like Aurobindo Pharma, Cadila Pharmaceuticals, and Granules India. IIFL Capital Services and Motilal Oswal Investment Advisors acted as book-running lead managers.

**How to check your allotment status:**

* **BSE:** https://www.bseindia.com/investors/appli_check.aspx
* **KFin Technologies:** https://rti.kfintech.com/ipostatus/

**Note:** GMP is an unofficial indicator and subject to change. This information is for general knowledge and does not constitute investment advice.

Read More